Di Rienzo Businco Lino, Di Rienzo Businco Andrea, Ventura Luca, Laurino Salvatore, Lauriello Maria
Department of Otorhinolaryngology, S. Spirito Hospital, Rome, Italy.
Am J Rhinol Allergy. 2014 Mar-Apr;28(2):164-8. doi: 10.2500/ajra.2014.28.3990.
Allergic rhinitis (AR) presents as the main and most invasive symptom in the blocking of the nose. This condition is almost always related to hypertrophy of the inferior turbinates. When the medical treatments are found to be insufficient to solve the obstructive symptom of the patient, the quality of life is considerably impaired and it is often necessary to submit the patient to a surgical approach. In the present study we aimed to establish the efficacy and safety of a new technique recently introduced for the shrinkage of hypertrophic turbinates using a specific device, based on a new radiofrequency energy that does not produce thermal mucosal damage, viz., quantic molecular resonance (QMR) in a group of patients with persistent moderate-severe allergic rhinitis, in addition to standard medical treatment (nasal steroid and oral antihistamine).
All patients were randomly assigned to two homogeneous groups (group A, control subjects; group B, treated patients); each group included 145 individuals. During the study, both groups received standard medications (ebastine, 10-mg tablet, and budesonide nasal spray at 100 micrograms/nostril per day) for 90 days. Before the medical treatment, patients in group B underwent inferior endoscopic turbinoplasty using QMR. All of the patients enrolled in this study were submitted to a complete otorhinolaryngologic evaluation with objective clinical examination (basal rhinomanometry, nasal provocation test rhinomanometry, and mucociliary transport time), endoscopy, and questionnaires (22-item Sino-Nasal Outcome Test and visual analog scale for nasal symptoms).
Greater efficacy has been achieved using a combined approach with the association of medical and QMR treatment, compared with medical treatment alone, in the control of AR associated with hypertrophy of the inferior turbinates, in particular in the reduction of turbinate volume at rhinoendoscopy.
QMR inferior turbinoplasty, in conjunction with medical therapy, improves the nasal flow, without any thermal mucosal damage, more effectively when compared with medical treatment alone in persistent moderate-to-severe AR. In particular, local reactivity, as measured with nasal provocation test, was noticeably reduced.
变应性鼻炎(AR)是鼻塞的主要且最具侵袭性的症状。这种情况几乎总是与下鼻甲肥大有关。当发现药物治疗不足以解决患者的阻塞性症状时,生活质量会受到相当大的损害,通常需要对患者采取手术治疗。在本研究中,我们旨在确定一种最近引入的新技术的疗效和安全性,该技术使用一种特定设备使肥大的鼻甲缩小,该设备基于一种不会产生热黏膜损伤的新型射频能量,即量子分子共振(QMR),用于一组持续性中重度变应性鼻炎患者,除了标准药物治疗(鼻用类固醇和口服抗组胺药)。
所有患者被随机分为两个同质组(A组,对照组;B组,治疗组);每组包括145名个体。在研究期间,两组均接受标准药物(依巴斯汀,10毫克片剂,以及布地奈德鼻喷雾剂,每天每侧鼻孔100微克)治疗90天。在药物治疗前,B组患者接受了使用QMR的鼻内镜下鼻甲成形术。本研究纳入的所有患者均接受了全面的耳鼻咽喉科评估,包括客观临床检查(基础鼻阻力测量、鼻激发试验鼻阻力测量和黏液纤毛传输时间)、内镜检查和问卷调查(22项鼻-鼻窦结局测试和鼻症状视觉模拟量表)。
与单独药物治疗相比,联合药物和QMR治疗在控制与下鼻甲肥大相关的AR方面取得了更大的疗效,特别是在鼻内镜检查中鼻甲体积的减小方面。
在持续性中重度AR中,与单独药物治疗相比,QMR鼻甲成形术联合药物治疗能更有效地改善鼻通气,且无任何热黏膜损伤。特别是,通过鼻激发试验测量的局部反应性明显降低。